新闻
2024-02-09
Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomatic GERD as the Second Naronapride Indication to Develop and Commercialize in their Licensed Territories
引进/卖出上市批准
2024-02-08
基因疗法临床申请并购
2024-02-08
Linnea SA of Switzerland and Universidade Estadual de Campinas (Unicamp) Brazil announce scientific partnership to promote cannabinoids research
2024-02-06
Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash
临床结果并购
2024-02-06
抗体药物偶联物引进/卖出
2024-02-05
疫苗并购
2024-02-02
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
上市批准并购免疫疗法生物类似药
2024-02-02
2月4款创新药有望获FDA批准
优先审批快速通道临床结果合格传染病产品
2024-02-01
临床3期申请上市高管变更
2024-01-31
抗体药物偶联物申请上市